Gilead Sciences, Inc.

Key Statistics

Recent News

• Gilead (GILD) Supports Faster South Africa Access to Lenacapavir Insider Monkey

  Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 7 Best Longevity Stocks to Buy Now. On June 5, 2026, Gilead Sciences, Inc. (NASDAQ:GILD) applauded the Government of South Africa and the Global Fund

• Is Gilead (GILD) One of the Top Large Cap Value Stocks to Buy Now? Insider Monkey

  Gilead Sciences Inc. (NASDAQ:GILD) is one of the top large cap value stocks to buy now. On June 8, Gilead Sciences and Merck announced positive topline results from two Phase 3 clinical trials, ISLEND

• Gilead Sciences, Inc. (GILD): a Top Deep Value Stock Making Progress on Pipeline Development Insider Monkey

  Gilead Sciences, Inc. (NASDAQ:GILD) is a deep value stock to invest in now. On June 2, Gilead Sciences, Inc. (NASDAQ:GILD) announced topline results of the Phase 3 IDEAL study for its candidate drug L

• Can Gilead Sciences HIV Franchise Drive Long-Term Growth? Zacks

  Gilead's HIV franchise gains momentum as Biktarvy and Descovy drive growth, Yeztugo outlook rises, and late-stage pipeline advances.

• Cencora Kite Deal Highlights CAR T Growth And Undervalued Share Price Potential Simply Wall St.

  Cencora (NYSE:COR) has entered a major U.S. distribution partnership with Kite Pharma, a Gilead company. The agreement focuses on market access and distribution support for FDA approved CAR T cell the

• Gilead, Merck Report Positive Phase III HIV Study Data, End NSCLC Study Zacks

  Gilead and Merck report positive phase III results for once-weekly HIV regimen islatravir/lenacapavir, while ending a lung cancer study.

• Gilead’s Mixed Trial News Puts HIV Progress And Oncology Risks In Focus Simply Wall St.

  Gilead Sciences (NasdaqGS:GILD) and Merck reported that their once weekly oral HIV regimen, islatravir and lenacapavir, met its primary endpoint in a Phase 3 trial, showing statistically non inferior

• Stocks Climb on an AI-Led Rebound Barchart

  The S&P 500 Index ($SPX ) (SPY ) today is up +0.93%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.89%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.17%. June E-mini S&P futures (ESM2